Stocktoria

ZIMMER BIOMET HOLDINGS, INC. ZBH

NYSE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2001-07-25 · LEI

ZIMMER BIOMET HOLDINGS, INC. statistics & valuation

Market cap$17.3B
P / E24.5×
P / S2.1×
P / B1.4×
P / FCF11.7×
Dividend yield1.10%
Net margin8.6%
Return on equity5.5%
FCF margin17.9%
Net debt$6.3B
Net debt / EBITDA2.9×
Enterprise value USD$23.6B
EV / EBITDA10.8×
Earnings yield EBIT/EV4.6%
Return on capital5.4%
Graham number -27%$71.47

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($71.47); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
4.00% 23.20% -4.80% 14.20% -2.30% 5.90% 3.30% 13.80% 11.80% 8.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
10.70% 10.20% 0.40% 14.30% 1.40% 12.60% 10.00% 17.30% 16.70% 13.30% 2016201720182019202020212022202320242025
Return on equity (%)
3.20% 15.50% -3.40% 9.10% -1.10% 3.20% 1.90% 8.20% 7.20% 5.50% 2016201720182019202020212022202320242025
Shares outstanding
202.4M 203.7M 203.5M 206.7M 207.0M 210.4M 210.3M 209.7M 203.9M 198.7M 2016201720182019202020212022202320242025
Net debt ($)
$10.03B $8.39B $7.87B $6.10B $6.82B $5.09B $4.78B $4.45B $4.82B $6.34B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
1.10% 7.00% -1.60% 4.60% -0.60% 1.70% 1.10% 4.80% 4.20% 3.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
18.90% 18.30% 20.00% 17.30% 17.80% 19.90% 16.80% 17.50% 16.90% 17.90% 2016201720182019202020212022202320242025
Debt / equity (×)
1.10× 0.76× 0.75× 0.54× 0.63× 0.43× 0.43× 0.39× 0.43× 0.55× 2016201720182019202020212022202320242025
EPS ($)
$1.51 $8.90 -$1.86 $5.47 -$0.67 $1.91 $1.10 $4.88 $4.43 $3.55 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ZIMMER BIOMET HOLDINGS, INC. trades at about 27.6× earnings — near its 10-year norm (10-year range 13.9×–125.2×, median 26.3×).

13.9× 125.2×

Shaded band = 10-year range (13.9×–125.2×); dot = today's 27.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin13.3%16.7%17.3%10.0%12.6%1.4%14.3%0.4%10.2%10.7%
Net margin8.6%11.8%13.8%3.3%5.9%-2.3%14.2%-4.8%23.2%4.0%
FCF margin17.9%16.9%17.5%16.8%19.9%17.8%17.3%20.0%18.3%18.9%
Return on assets3.1%4.2%4.8%1.1%1.7%-0.6%4.6%-1.6%7.0%1.1%
Return on equity5.5%7.2%8.2%1.9%3.2%-1.1%9.1%-3.4%15.5%3.2%
Debt / equity0.55×0.43×0.39×0.43×0.43×0.63×0.54×0.75×0.76×1.10×
Current ratio1.981.911.611.881.411.991.371.831.491.96

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.